Shandong Wohua Pharmaceutical Co Ltd (002107) — Cash Flow Reinvestment Rate
Shandong Wohua Pharmaceutical Co Ltd (002107) has a Cash Flow Reinvestment Rate of 0.02x as of December 2025, reinvesting CN¥317.82K (capex CN¥317.82K ) from operating cash flow of CN¥19.82 Million. See free cash flow generation of Shandong Wohua Pharmaceutical Co Ltd to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Shandong Wohua Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (2003–2025)
Historical reinvestment intensity for Shandong Wohua Pharmaceutical Co Ltd across 21 annual periods. For the full cash flow conversion analysis, see Shandong Wohua Pharmaceutical Co Ltd (002107) cash flow conversion.
Annual Cash Flow Reinvestment Rate for Shandong Wohua Pharmaceutical Co Ltd (2003–2025)
Year-by-year capital reinvestment analysis for Shandong Wohua Pharmaceutical Co Ltd. See 002107 FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.01x | CN¥864.51K | CN¥128.53 Million | CN¥864.51K | ▼ -91.7% |
| 2024 | 0.08x | CN¥7.42 Million | CN¥91.51 Million | CN¥3.82 Million | ▲ +96.4% |
| 2023 | 0.04x | CN¥5.34 Million | CN¥129.25 Million | CN¥2.72 Million | ▼ -38.1% |
| 2022 | 0.07x | CN¥12.37 Million | CN¥185.26 Million | CN¥6.77 Million | ▼ -65.0% |
| 2021 | 0.19x | CN¥38.15 Million | CN¥200.12 Million | CN¥19.08 Million | ▼ -52.5% |
| 2020 | 0.40x | CN¥78.91 Million | CN¥196.58 Million | CN¥54.17 Million | ▼ -81.1% |
| 2019 | 2.13x | CN¥67.39 Million | CN¥31.66 Million | CN¥32.23 Million | ▲ +83.3% |
| 2018 | 1.16x | CN¥125.32 Million | CN¥107.88 Million | CN¥63.10 Million | ▲ +377.9% |
| 2017 | 0.24x | CN¥30.11 Million | CN¥123.88 Million | CN¥15.07 Million | ▼ -66.1% |
| 2016 | 0.72x | CN¥52.29 Million | CN¥72.91 Million | CN¥27.66 Million | ▲ +892.7% |
| 2015 | 0.07x | CN¥9.60 Million | CN¥132.82 Million | CN¥9.60 Million | ▼ -43.9% |
| 2014 | 0.13x | CN¥3.43 Million | CN¥26.58 Million | CN¥3.43 Million | ▼ -86.3% |
| 2013 | 0.94x | CN¥14.25 Million | CN¥15.15 Million | CN¥14.25 Million | ▲ +19.5% |
| 2012 | 0.79x | CN¥26.65 Million | CN¥33.86 Million | CN¥26.65 Million | ▼ -97.1% |
| 2011 | 27.05x | CN¥36.84 Million | CN¥1.36 Million | CN¥36.84 Million | ▲ +1731.1% |
| 2008 | 1.48x | CN¥52.58 Million | CN¥35.59 Million | CN¥52.58 Million | ▼ -71.7% |
| 2007 | 5.21x | CN¥54.52 Million | CN¥10.46 Million | CN¥54.52 Million | ▲ +262.1% |
| 2006 | 1.44x | CN¥66.32 Million | CN¥46.05 Million | CN¥66.32 Million | ▲ +92.2% |
| 2005 | 0.75x | CN¥9.75 Million | CN¥13.01 Million | CN¥9.75 Million | ▲ +3524.5% |
| 2004 | 0.02x | CN¥698.06K | CN¥33.77 Million | CN¥698.06K | ▼ -85.5% |
| 2003 | 0.14x | CN¥2.59 Million | CN¥18.17 Million | CN¥2.59 Million | — |